Business Context and Reporting Period
This summary covers the Form 10-Q filed by Torchmark Corporation (doing business as Globe Life Inc. in some contexts, though the filing header lists Torchmark) for the quarter and six months ended June 30, 2001. Torchmark operates in the life insurance, health insurance, and annuity sectors, with a significant investment portfolio managing assets for these segments.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2001 | Six Months Ended June 30, 2000 |
|---|---|---|
| Total Revenue | $1,363.8 million | $1,234.2 million |
| Total Premiums | $1,108.1 million | $1,009.9 million |
| Net Investment Income | $243.6 million | $234.5 million |
| Net Income | $169.6 million | $172.2 million |
| Net Operating Income (Non-GAAP) | $193.5 million | $179.8 million |
| Diluted EPS (Net Income) | $1.34 | $1.33 |
| Diluted EPS (Net Operating Income) | $1.53 | $1.39 |
| Total Assets | $12,503.4 million | $12,962.6 million (Dec 31, 2000) |
| Total Debt | $664.0 million | $695.0 million (Dec 31, 2000) |
| Cash & Short-term Investments | $112.5 million | $135.6 million (Dec 31, 2000) |
| Shareholders' Equity | $2,371.5 million | $2,202.4 million (Dec 31, 2000) |
Material Changes vs. Prior Period
- Revenue Growth: Total operating revenue increased 9% to $1.4 billion, driven by a 10% increase in total premiums and a 4% rise in net investment income.
- Accounting Change Impact: Net income was reduced by a $26.6 million after-tax charge due to the adoption of a new accounting standard (EITF 99-20) regarding asset-backed securities. This resulted in a $41 million impairment charge.
- Segment Performance:
- Life Insurance: Premiums rose 6% to $570 million; underwriting income increased 5%.
- Health Insurance: Premiums grew 13% to $507 million; underwriting income increased 12%.
- Annuities: Collections declined significantly (65% drop) due to market declines and the termination of the Waddell & Reed distribution agreement. Underwriting income fell 5%.
- Capital Actions: The company redeemed $50 million of Monthly Income Preferred Securities (MIPS) and repurchased $54.5 million of its own common stock.
- Investment Portfolio: The fixed-maturity portfolio held an unrealized loss of $112 million at June 30, 2001, a significant improvement from the $339 million unrealized loss at the same time in 2000.
Guidance, Outlook, and Risks
- Outlook: Management emphasizes "net operating income" to evaluate performance, excluding non-recurring items. They do not expect to emphasize the growth of the variable annuity product line in the future following the loss of their primary distributor.
- Legal Risks: The company faces significant litigation exposure, particularly in Alabama, where punitive damages can be substantial.
- Moore v. Liberty: A class action alleging racial discrimination in premium rates is pending. The Eleventh Circuit is reviewing the applicability of the state law of repose.
- Regulatory Investigations: State insurance departments (including Florida, Georgia, and Alabama) are investigating historical use of race-based mortality tables and sales practices.
- Pending Litigation: Liberty National Life Insurance Company is a party to approximately 94 active lawsuits, 72 of which seek punitive damages in Alabama.
- Market Risks: The company notes risks related to interest rate changes, mortality/morbidity levels, and regulatory changes affecting Medicare Supplement insurance.
- Accounting Standards: The company will adopt SFAS No. 142 (Goodwill) on January 1, 2002, which will cease goodwill amortization (currently ~$12 million annually) and replace it with an impairment test.
Investor Verification Checklist
- Verify the impact of the $26.6 million accounting change charge on future earnings and the remaining exposure to asset-backed securities ($24 million at fair value).
- Monitor the status of the Moore v. Liberty class action and other Alabama litigation, specifically regarding the potential for large punitive damage awards.
- Assess the long-term impact of the termination of the Waddell & Reed distribution agreement on annuity sales and the success of finding successor distributors.
- Review the Medicare Supplement sales trends, noting the recent slowdown in Q2 2001 and the uncertainty regarding forced disenrollees from Medicare HMOs.
- Confirm the company's ability to maintain its debt-to-capitalization ratio (20.4% excluding MIPS) amidst continued share repurchases and debt redemptions.